F(ab')2 prepared from the murine SA23.2 IgM mAb bound more strongly to sLeA-positive colon adenocarcinomas, pancreatic, stomach, and lung cancers, and showed much less unspecific binding than the original IgM 125. The gene discussed is CD40LG; the disease is lung cancer.